Antibody Pair for Matrix Gla Protein (MGP) 
MGLAP; GIG36; Cell growth-inhibiting gene 36 protein
- UOM
- FOB US$ 898.00 US$ 1,496.00 US$ 2,693.00 US$ 5,236.00 US$ 8,976.00
- Quantity
Overview
Properties
- Product No.PSB477Hu01
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- ApplicationsELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
Research use only - DownloadInstruction Manual
- CategoryMetabolic pathwayHematologyBone metabolism
-
Reagent Contents
Recombinant Matrix Gla Protein (MGP) 10ug Standard Monoclonal Antibody to Matrix Gla Protein (MGP) 400ug Capture Ab
Share your citation
Upload your experimental result
Review
Leave a message
Loading...
Sign into your account
Share a new citation as an author
Upload your experimental result
Review
Please attach serial No. on instruction manual
Contact us
Please fill in the blank.
Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code*
-
Packages (Simulation)
-
Packages (Simulation)
-
ISO9001: 2008, ISO13485: 2003 Registered
Matching tests
Usage
Storage
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
Stability
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Giveaways
Increment services
Citations
- Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cellsPubMed: PMC3611891
- Bone metabolism regulators and arterial stiffness in postmenopausal womenPubmed: 23916080
- Osteoprotegerin (OPG) and Matrix Gla protein (MGP) in rheumatoid arthritis patients: Relation to disease activityScienceDirect: S1110116414000076
- Canola and hydrogenated soybean oils accelerate ectopic bone formation induced by implantation of bone morphogenetic protein in miceResearchgate:Source
- Markers of increased cardiovascular risk in patients with chronic kidney diseaseBiomedcentral:Source
- The behavior of circulating matrix Gla protein, matrix metalloproteinase-9 and nitrotyrosine in patients with varicose veinsHvm:Source
- Effect of Vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3-5PubMed: 26176325
- Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary studypmc:PMC4739105
- Plasma Desphospho-Uncarboxylated Matrix Gla Protein as a Marker of Kidney Damage and Cardiovascular Risk in Advanced Stage of Chronic Kidney DiseasePubmed:27100101
- Matrix-Gla Protein rs4236 [A/G] gene polymorphism and serum and GCF levels of MGP in patients with subgingival dental calculuspubmed:27348051
- Mesenchymal stromal cells-derived matrix Gla protein contribute to the alleviation of experimental colitisPubmed:29880866
- High concentration of calcium promotes mineralization in NRK52E cells via inhibiting the expression of matrix Gla proteinPubmed:29935264
- Serum total matrix Gla protein: Reference interval in healthy adults and variations in patients with vascular and osteoarticular diseasesPubmed: 30597137
- Altered Mineral Metabolism and Disequilibrium Between Calcification Promoters and Inhibitors in Chronic Hemodialysis PatientsPubmed: 30847765
- Relationship of matrix Gla protein and vitamin K with vascular calcification in hemodialysis patientsPubmed: 31538831
- Matrix Gla protein maintains normal and malignant hematopoietic progenitor cells by interacting with bone morphogenetic protein-4Pubmed: 32322728